Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Share News (CIR)

  • There is currently no data for CIR

Wednesday broker round-up UPDATE

Wed, 18th Jun 2014 09:03
Ashtead Group: Barclays ups target price from 930p to 946p retaining its overweight rating.Berkeley Group: Numis upgrades from hold to buy with a target price of 2491p.Brown (N) Group: Oriel places its buy recommendation under review.BT Group: Jefferies ups target price from 440p to 470p and keeps a buy recommendation.Circassia Pharmaceuticals: Oriel initiates with a target price of 320p and an add rating.Consort Medical: Canaccord Genuity shifts target price from 1044p to 1045p and stays with its buy recommendation.Daily Mail & General Trust: Investec places its target price (prev.:Ñ 1052p) under review, while leaving its buy recommendation unchanged.Faroe Petroleum: Canaccord Genuity lowers target price from 195p to 180p and keeps a buy recommendation.Gemfields: FinnCap places its target price and recommendation under review. Canaccord Genuity moves target price from 40p to 620p and moves from a buy recommendation to a speculative buy. Investec places both its target price (prev.: 42.5p) and its buy recommendation under review. JP Morgan moves target price from 37p to 47p keeping a neutral rating.Genel Energy: Oriel downgrades from buy to reduce with a target price of 900p.Mitchells & Butlers: Citi ups target price from 500p to 520p and retains a buy recommendation.Oxford Instruments: Investec ups target price from 1500p to 1550p upgrading from add to buy.Rame Energy: Northland Capital starts with a target price of 31p and a buy recommendation.Randall & Quilter: Numis downgrades from buy to add with a target price of 165p.Royal Mail Group: Jefferies initiates with a target price of 420p and maintains an underperform rating.Smiths Group: Berenberg cuts target price from 1485p to 1405p retaining its buy recommendation.Sound Oil: Westhouse Securities shifts target price from 8.7p to 14p and retains its add rating.St. Ives: Numis shifts target price from 252p to 259p and maintains a buy recommendation.Stobart: Oriel initiates with a target price of 180p and a buy recommendation.TLA Worldwide: Numis shifts target price from 45p to 52p upgrading from add to buy.Whitbread: Morgan Stanley raises target price from 4400p to 4600p and retains an equal-weight rating.Xaar: UBS reduces target price from 950p to 550p, while leaving its neutral rating unchanged. Investec reduces target price from 960p to 560p downgrading from buy to hold.

Related News

Gemfields shares tumble as CEO Sean Gilbertson exits amid challenges
1 day ago

Gemfields shares tumble as CEO Sean Gilbertson exits amid challenges

(Alliance News) - Gemfields Group Ltd said on Tuesday Chief Executive Officer Sean Gilbertson will step down, with effect from July 15.

Smiths Group completes detection unit sale in GBP2 billion deal
1 day ago

Smiths Group completes detection unit sale in GBP2 billion deal

(Alliance News) - Smiths Group PLC on Tuesday said it had completed the sale of Smiths Detection to private equity firm CVC Capital Partners PLC, at a...

Gemfields generates $23.1m in auction, warns of Montepuez issues
1 day ago

Gemfields generates $23.1m in auction, warns of Montepuez issues

(Sharecast News) - Gemfields said on Tuesday that its first Trade Select ruby auction generated $23.1m, although it warned that lower grades, plant co...

CIR.L News

AIM WINNERS & LOSERS: Kibo extends contract; Appreciate CEO steps down
14 Jul 2022

AIM WINNERS & LOSERS: Kibo extends contract; Appreciate CEO steps down

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Circassia ups guidance as revenue rises, overhead costs slashed
14 Jul 2022

Circassia ups guidance as revenue rises, overhead costs slashed

(Allaince News) - Circassia Group PLC on Thursday said that its expects to outperform full-year guidance, amid "strong" revenue growth and cost cuttin...

IN BRIEF: Circassia gets USD10.5 million after BeyondAir US FDA win
29 Jun 2022

IN BRIEF: Circassia gets USD10.5 million after BeyondAir US FDA win

Circassia Group PLC - Oxford, England-based medical device focused on point-of-care asthma diagnosis and management - Says BeyondAir Inc has won appro...

IN BRIEF: Circassia's revenue in first four months beats expectations
12 May 2022

IN BRIEF: Circassia's revenue in first four months beats expectations

Circassia Group PLC - Oxford, England-based medical device focused on point-of-care asthma diagnosis and management - Posts higher revenue in the firs...

DIRECTOR DEALINGS: Capital Ltd exec sells GBP1.4 million in shares
29 Mar 2022

DIRECTOR DEALINGS: Capital Ltd exec sells GBP1.4 million in shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Tuesday and not separatel...

Circassia records increased revenue and narrowed loss in 2021
22 Mar 2022

Circassia records increased revenue and narrowed loss in 2021

(Alliance News) - Circassia Group PLC on Tuesday reported increased revenue and a narrowed loss for 2021, on a higher contribution from its Niox arm.